Cite

HARVARD Citation

    Monti Guarnieri, N. et al. (n.d.). 4CPS-217 The use of cystic fibrosis conductance regulator modulators in patients with rare mutation. European journal of hospital pharmacy. 30 (1), pp. A95-A96. [Online]. 
  
Back to record